ICD-10-CM Code C67.6

Malignant neoplasm of ureteric orifice

Version 2020 Billable Code Neoplasm Malignant Primary

Valid for Submission

C67.6 is a billable code used to specify a medical diagnosis of malignant neoplasm of ureteric orifice. The code is valid for the year 2020 for the submission of HIPAA-covered transactions. The ICD-10-CM code C67.6 might also be used to specify conditions or terms like malignant tumor of ureteric orifice or neoplasm of ureteric orifice of urinary bladder or primary malignant neoplasm of ureter or primary malignant neoplasm of ureteric orifice of urinary bladder.

The following anatomical sites found in the Table of Neoplasms apply to this code given the correct histological behavior: bladder (urinary) orifice ureteric or ureter, ureteral orifice (bladder) or ureter-bladder (junction) .

ICD-10:C67.6
Short Description:Malignant neoplasm of ureteric orifice
Long Description:Malignant neoplasm of ureteric orifice

Synonyms

The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:

  • Malignant tumor of ureteric orifice
  • Neoplasm of ureteric orifice of urinary bladder
  • Primary malignant neoplasm of ureter
  • Primary malignant neoplasm of ureteric orifice of urinary bladder

Diagnostic Related Groups

The ICD-10 code C67.6 is grouped in the following groups for version MS-DRG V37.0 What are Diagnostic Related Groups?
The Diagnostic Related Groups (DRGs) are a patient classification scheme which provides a means of relating the type of patients a hospital treats. The DRGs divides all possible principal diagnoses into mutually exclusive principal diagnosis areas referred to as Major Diagnostic Categories (MDC).
applicable from 10/01/2020 through 09/30/2020.

  • 656 - KIDNEY AND URETER PROCEDURES FOR NEOPLASM WITH MCC
  • 657 - KIDNEY AND URETER PROCEDURES FOR NEOPLASM WITH CC
  • 658 - KIDNEY AND URETER PROCEDURES FOR NEOPLASM WITHOUT CC/MCC

Convert C67.6 to ICD-9

  • 188.6 - Mal neo ureteric orifice

Code Classification

  • Neoplasms (C00–D48)
    • Malignant neoplasms of urinary tract (C64-C68)
      • Malignant neoplasm of bladder (C67)

Code History

  • FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016
    (First year ICD-10-CM implemented into the HIPAA code set)
  • FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
  • FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
  • FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
  • FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020

Table of Neoplasms

The code C67.6 is included in the table of neoplasms by anatomical site. For each site there are six possible code numbers according to whether the neoplasm in question is malignant, benign, in situ, of uncertain behavior, or of unspecified nature. The description of the neoplasm will often indicate which of the six columns is appropriate.

Where such descriptors are not present, the remainder of the Index should be consulted where guidance is given to the appropriate column for each morphological (histological) variety listed. However, the guidance in the Index can be overridden if one of the descriptors mentioned above is present.

Neoplasm, neoplastic Malignant
Primary
Malignant
Secondary
CaInSitu Benign Uncertain
Behavior
Unspecified
Behavior
»bladder (urinary)
  »orifice
    »ureteric
C67.6C79.11D09.0D30.3D41.4D49.4
»ureter, ureteral
  »orifice (bladder)
C67.6C79.11D09.0D30.3D41.4D49.4
»ureter-bladder (junction)
C67.6C79.11D09.0D30.3D41.4D49.4

Information for Patients


Bladder Cancer

The bladder is a hollow organ in your lower abdomen that stores urine. Bladder cancer occurs in the lining of the bladder. It is the sixth most common type of cancer in the United States.

Symptoms include

  • Blood in your urine
  • A frequent urge to urinate
  • Pain when you urinate
  • Low back pain

Risk factors for developing bladder cancer include smoking and exposure to certain chemicals in the workplace. People with a family history of bladder cancer or who are older, white, or male have a higher risk.

Treatments for bladder cancer include surgery, radiation therapy, chemotherapy, and biologic therapy. Biologic therapy boosts your body's own ability to fight cancer.

NIH: National Cancer Institute


[Learn More]

Bladder cancer Bladder cancer is a disease in which certain cells in the bladder become abnormal and multiply without control or order. The bladder is a hollow, muscular organ in the lower abdomen that stores urine until it is ready to be excreted from the body. The most common type of bladder cancer begins in cells lining the inside of the bladder and is called transitional cell carcinoma (TCC).Bladder cancer may cause blood in the urine, pain during urination, frequent urination, or the feeling that one needs to urinate without results. These signs and symptoms are not specific to bladder cancer, however. They also can be caused by noncancerous conditions such as infections.
[Learn More]